DUBLIN, Jan. 19, 2018 /PRNewswire/ --
The "Tumor Markers Immunoassay Market (PSA, CEA, CA 125, AFP, CA 15-3, CA 19-9, CYFRA 21-1, ProGRP, SCC, CA 72-4, HE4, Others)" report has been added to ResearchAndMarkets.com's offering.
Immunoassays have played a role in cancer management since the 1960s with the discovery of tumor markers alpha-fetoprotein (AFP) and carcinoembryonic antigen (CEA). These two tests are still an essential part of the cancer diagnostics toolbox.
Tumor Markers Immunoassay Market provides analysis of the current global market, including the following data points:
Biomarkers are biological or biochemical molecules, or genetic changes, or other characteristics that can be measured, and that indicate or predict a condition, risk, or likely response. Biomarkers can be used for a range of diagnostic applications including predicting disease risk, diagnosis, predicting prognosis, identifying appropriate therapy for an individual, monitoring disease or for return of a disease, and other applications.
Much of the activity in the development and use of new biomarkers is in the field of oncology, where both single biomarkers and also biomarker panels are being developed and used for a wide range of applications - assessing risk of developing cancer, screening apparently healthy individuals for cancer, diagnosis of cancer, predicting prognosis, monitoring patients including monitoring for recurrence of disease, and determining the best therapy for treatment of a patient.
Researchers are continuing to try to identify and validate new tumor biomarkers, but this has proven to be a slow process. Still, biomarker assays are being developed and added to the menus of large analyzers.
Key Topics Covered:
1: Executive Summary
OVERVIEW
Table 1-1: Selected Widely Used Tumor Markers
CONCLUSIONS
The Current Global Market
The Tumor Markers Market Is at the Same Time Impressive and Distressing
Researchers Are Continuing to Try to Identify and Validate New Tumor Biomarkers
2: Tumor Markers Immunoassay Market: Analysis
TUMOR MARKERS
AFP (alfa-fetoprotein)
Beta HCG
CA 125
CA 15-3
CA 19-9
CEA (carcinoembryonic antigen)
CYFRA 21-1
HE4 (human epididymis protein 4)
ProGRP
PSA (complexed, free, total))
SCC (squamous cell carcinoma antigen)
Serum HER-2/neu
Thyroglobulin
CA 72-4
COMPANIES IN THE MARKET
MARKET ANALYSIS
3: Company Profiles
For more information about this report visit https://www.researchandmarkets.com/research/pxxzzn/tumor_markers?w=5
Media Contact:
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
SOURCE Research and Markets
These press releases may also interest you
|